Lexaria Bioscience Equity Warrant Exp 12 Jan 2026 LEXXW:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/16/24 EDT
1.35UNCH (UNCH)
Volume
1,452
52 week range
0.05 - 2.50
Loading...
  • Open1.17
  • Day High1.35
  • Day Low1.17
  • Prev Close1.35
  • 52 Week High2.50
  • 52 Week High Date03/11/24
  • 52 Week Low0.05
  • 52 Week Low Date10/23/23

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open1.17
  • Day High1.35
  • Day Low1.17
  • Prev Close1.35
  • 52 Week High2.50
  • 52 Week High Date03/11/24
  • 52 Week Low0.05
  • 52 Week Low Date10/23/23
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Lexaria Bioscience Equity Warrant Exp 12 Jan 2026

 

Profile

MORE
Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced...
Christopher Bunka
Chairman of the Board, Chief Executive Officer
John Docherty
President, Director
Nelson Cabatuan CPA
Chief Financial Officer
Address
100 - 740 MCCURDY ROAD
Kelowna, BC
V1X 2P7
Canada